Latest filing published 18 Oct 2022 for AGIOS PHARMACEUTICALS, INC., €41k.
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Richa Poddar: trading record in brief
This profile gathers the share dealings of Richa Poddar in Agios Pharmaceuticals, Inc., where the filings describe the role as senior executive. Over a trading history stretching from 10 February 2022 to 17 October 2022, the count stands at 9 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The record was last updated on 18 October 2022 with a share grant (€41k) in Agios Pharmaceuticals, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Richa Poddar
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,485 shares@ US$27.48100.0% of flowCommon stockSEC:0001439222-22-000091:1
- 5,000 shares0Common stockSEC:0001439222-22-000091:0
- 1,884 shares0Common stockSEC:0001439222-22-000020:0
- 1,738 shares0Common stockSEC:0001439222-22-000010:0
- 2,068 shares0Common stockSEC:0001439222-22-000003:0
5 of 5 declarations
